{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:53:33Z","timestamp":1793832813226,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2024.113925","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:59:27Z","timestamp":1736211567000},"page":"113925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Hedyotis diffusa injection modulates the ferroptosis in bladder cancer via CAV1\/JUN\/VEGFA"],"prefix":"10.1016","volume":"147","author":[{"given":"Kaiping","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.intimp.2024.113925_b0005","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1038\/s41388-019-0741-6","article-title":"Connexins in cancer: bridging the gap to the clinic","volume":"38","author":"Aasen","year":"2019","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.intimp.2024.113925_b0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.trecan.2022.03.007","article-title":"Natural killer cells: unlocking new treatments for bladder cancer","volume":"8","author":"Ranti","year":"2022","journal-title":"Trends Cancer."},{"issue":"2","key":"10.1016\/j.intimp.2024.113925_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.113925_b0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"10.1016\/j.intimp.2024.113925_b0025","first-page":"11536","article-title":"Advanced\/metastatic bladder cancer: current status and future directions","volume":"24","author":"Facchini","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.113925_b0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bju.13760","article-title":"Guideline of guidelines: non-muscle-invasive bladder cancer","volume":"119","author":"Woldu","year":"2017","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur. Urol."},{"issue":"7679","key":"10.1016\/j.intimp.2024.113925_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2024.113925_b0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11912-023-01390-9","article-title":"Current status of perioperative therapy in muscle-invasive bladder cancer and future directions [published correction appears in Curr Oncol Rep. 2023 Apr 20]","volume":"25","author":"Cockrell","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.intimp.2024.113925_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","article-title":"Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them","volume":"149","author":"Koch","year":"2021","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.intimp.2024.113925_b0055","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"14","key":"10.1016\/j.intimp.2024.113925_b0060","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2024.113925_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043283","article-title":"Ferroptosis: a new therapeutic target for bladder cancer","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113925_b0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113925_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101302","article-title":"Systematic analysis of the aberrances and functional implications of ferroptosis in cancer","volume":"23","author":"Liu","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2024.113925_b0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2020.07.026","article-title":"Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell","volume":"160","author":"Bai","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113925_b0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113925_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113925_b0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20220020","article-title":"Nurturing the marriages of urinary liquid biopsies and nano-diagnostics for precision urinalysis of prostate cancer","volume":"2","author":"Liao","year":"2023","journal-title":"Smart Med."},{"key":"10.1016\/j.intimp.2024.113925_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111381","article-title":"Traditional Chinese medicine and lung cancer\u2013from theory to practice","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113925_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174275","article-title":"Anticancer effects of Traditional Chinese Medicine on epithelial-mesenchymal transition (EMT) in breast cancer: cellular and molecular targets","volume":"907","author":"Lu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0254-6272(14)60062-5","article-title":"Research progress on synergistic anti-tumor mechanisms of compounds in traditional Chinese medicine","volume":"34","author":"Zhou","year":"2014","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.intimp.2024.113925_b0125","article-title":"Molecular mechanism of anti-colorectal cancer effect of Hedyotis diffusa Willd and its extracts","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113925_b0130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/bph.15350","article-title":"Quercetin induces p53-independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species-dependent ferroptosis","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"Database issue","key":"10.1016\/j.intimp.2024.113925_b0135","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.intimp.2024.113925_b0140","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.113925_b0145","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume":"13","author":"Xu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113925_b0150","article-title":"Effect of fushengong decoction on PTEN\/PI3K\/AKT\/NF-\u03baB pathway in rats with chronic renal failure via dual-dimension network pharmacology strategy","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113925_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1416841","article-title":"Network pharmacology analysis and experimental verification on antiangiogenesis mechanism of Hedyotis diffusa Willd in liver cancer","volume":"2023","author":"Wu","year":"2023","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"12","key":"10.1016\/j.intimp.2024.113925_b0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033323","article-title":"Exploring the mechanism of action of Hedyotis diffusa Willd on acne using networkanalysis","volume":"102","author":"Seo","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"D1","key":"10.1016\/j.intimp.2024.113925_b0165","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","article-title":"MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search","volume":"45","author":"Rappaport","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2024.113925_b0170","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaa021","article-title":"FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations","volume":"2020","author":"Zhou","year":"2020","journal-title":"Database (Oxford)"},{"issue":"Database issue","key":"10.1016\/j.intimp.2024.113925_b0175","first-page":"D991","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.113925_b0180","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13059-021-02356-5","article-title":"A generalization of t-SNE and UMAP to single-cell multimodal omics","volume":"22","author":"Do","year":"2021","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113925_b0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113925_b0195","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3934\/mbe.2021065","article-title":"Integration of single-cell and bulk RNA sequencing data reveals key cell types and regulators in traumatic brain injury","volume":"18","author":"Zheng","year":"2021","journal-title":"Math. Biosci. Eng."},{"issue":"7","key":"10.1016\/j.intimp.2024.113925_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113925_b0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.intimp.2024.113925_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ctrv.2017.12.007","article-title":"Immune checkpoint inhibitors for metastatic bladder cancer","volume":"64","author":"Massari","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2024.113925_b0215","article-title":"Targeted therapies in bladder cancer: signaling pathways, applications, and challenges","volume":"4","author":"Peng","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.intimp.2024.113925_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102142","article-title":"Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: what to expect in the near future","volume":"93","author":"Rey-C\u00e1rdenas","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.intimp.2024.113925_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113929","article-title":"Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways","volume":"156","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.intimp.2024.113925_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122101","article-title":"The antitumor constituents from Hedyotis Diffusa Willd","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.intimp.2024.113925_b0235","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.3390\/cimb45100517","article-title":"Ferroptosis: an emerging target for bladder cancer therapy","volume":"45","author":"Shan","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.intimp.2024.113925_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.775506","article-title":"Natural product erianin inhibits bladder cancer cell growth by inducing ferroptosis via NRF2 inactivation","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113925_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110735","article-title":"Antitumor potential of Hedyotis diffusa Willd: a systematic review of bioactive constituents and underlying molecular mechanisms","volume":"130","author":"Han","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.intimp.2024.113925_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133177","article-title":"The anti-cancer effect of quercetin: molecular implications in cancer metabolism","volume":"20","author":"Reyes-Farias","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.113925_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21060710","article-title":"The Hedyotis diffusa Willd. (Rubiaceae): a review on phytochemistry, pharmacology, quality control and pharmacokinetics","volume":"21","author":"Chen","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113925_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109604","article-title":"Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects","volume":"121","author":"Tang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.intimp.2024.113925_b0265","article-title":"The evaluation of vascular endothelial growth factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer","volume":"13","author":"El Azzouzi","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.intimp.2024.113925_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101666","article-title":"TJP1 promotes vascular mimicry in bladder cancer by facilitating VEGFA expression and transcriptional activity through TWIST1","volume":"32","author":"Dong","year":"2023","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113925_b0275","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/or.2012.1948","article-title":"Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder","volume":"28","author":"Zaravinos","year":"2012","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2024.113925_b0280","first-page":"4866","article-title":"The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy","volume":"6","author":"Inoue","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2024.113925_b0285","doi-asserted-by":"crossref","first-page":"21871","DOI":"10.18632\/oncotarget.15669","article-title":"Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer","volume":"8","author":"Poyet","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.intimp.2024.113925_b0290","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1074\/jbc.M110.175158","article-title":"Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site","volume":"286","author":"Oommen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0295","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-023-00635-4","article-title":"The promotion action of AURKA on post-ischemic angiogenesis in diabetes-related limb ischemia","volume":"29","author":"Bai","year":"2023","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-016-0558-7","article-title":"Caveolin-1 in the regulation of cell metabolism: a cancer perspective","volume":"15","author":"Nwosu","year":"2016","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.113925_b0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.euf.2017.06.011","article-title":"Caveolin-1 expression in upper tract urothelial carcinoma","volume":"5","author":"D'Andrea","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.intimp.2024.113925_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.986269","article-title":"Caveolin-1, GATA-3, and Ki67 expressions and their correlation with pathological findings in canine bladder urothelial carcinoma","volume":"9","author":"Govoni","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.intimp.2024.113925_b0315","article-title":"Identification of potential ferroptosis-related biomarkers and a pharmacological compound in diabetic retinopathy based on machine learning and molecular docking","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2024.113925_b0320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.freeradbiomed.2019.12.026","article-title":"Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress","volume":"148","author":"Deng","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.113925_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154117","article-title":"Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice","volume":"101","author":"Huang","year":"2022","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.intimp.2024.113925_b0330","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1073\/pnas.1717956115","article-title":"Single-molecule analysis of phospholipid scrambling by TMEM16F","volume":"115","author":"Watanabe","year":"2018","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.intimp.2024.113925_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28124643","article-title":"Terpinen-4-ol induces ferroptosis of glioma cells via downregulating JUN proto-oncogene","volume":"28","author":"Cao","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113925_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107370","article-title":"Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes","volume":"165","author":"Li","year":"2023","journal-title":"Comput. Biol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:55:12Z","timestamp":1740617712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":68,"alternative-id":["S1567576924024470"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113925","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hedyotis diffusa injection modulates the ferroptosis in bladder cancer via CAV1\/JUN\/VEGFA","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113925"}}